Last August, CHPSO warned of the frequent appearance of opioids
and benzodiazepines (BZD) in medication events in the CHPSO
events database. Coincidentally, several weeks later the FDA
initiated black-box warnings advising against using BZDs with
opioids, based on the increased risk of death with the
combination. Additionally, BZD-like sedative hypnotics (BZD-SH)
such as eszopiclone, zaleplon and zolpidem should pose a similar
risk given their similar mechanism of action.
According to the Health Research & Educational Trust (HRET), hospital acquired pressure injuries (HAPI), commonly referred to as hospital acquired pressure ulcers (HAPU), affect more than 2.5 million patients in the U.S., resulting in significant patient harm including pain, expensive treatments, increased length of stay, and premature mortality. The cost of treating a single full-thickness pressure ulcer or injury can be as high as $70,000, and estimated total costs for treatment of pressure ulcer or injury in the U.S. is at $11 billion annually.
Quality and Patient safety positions at your organization may be
listed on the CHPSO Job Board. If you are a member of CHPSO, the
California Hospital Association or key partner of the Hospital
Quality Institute and would like to list your opportunities on
this page, please contact email@example.com. The listings are
available at http://www.chpso.org/career-opportunities.